Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07323329 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization

StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 7, 2026 (before its estimated October 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The goal of this study is to evaluate the role of Somatropin and Dehydroepiandrosterone (DHEA) on ovarian reserve parameters and intracytoplasmic sperm injection (ICSI) outcome in poor ovarian responder. The main question it aims to answer is: Which intervention is more effective in increasing number and size of follicles? Participants will be followed 1 month before starting induction in growth hormone and 12 weeks for DHEA and through intracytoplasmic sperm injection (ICSI) cycle.
Trial Details
NCT Number NCT07323329
Lead Sponsor Beni-Suef University
Conditions
(from sponsor)		 Infertility, Infertility (IVF Patients)
Related terms Infertility
Enrollment 165 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov